At ID Week 2022, VA executives presented a poster session titled, highlighting how high-risk patients with mild to moderate disease were identified as a group who would benefit from COVID-19 monoclonal antibody (mAB) treatment to mitigate progression to severe disease or hospitalization.
Read MoreOne of the biggest challenges that VA hospitals and clinicians face is effectively providing Veterans with 100 percent of care services throughout their lifetimes. Thankfully this challenge can be met with TheraDoc. Read more in DSS’ latest HIT Consultant guest article.
Read MoreThe CDC estimates 30-50 percent of antibiotics prescribed in hospitals are either inappropriate or unnecessary. In response, three VA medical centers (VACMs) are fighting back with TheraDoc, DSS’s industry leading software decision support tool that provides real-time electronic clinical surveillance for antimicrobial stewardship and infectious disease.
Read More